Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1247677.RAejWVIaC_CyYFUIxgIRbvP80wtKpF47TeuCk4vkHB7p0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1247677.RAejWVIaC_CyYFUIxgIRbvP80wtKpF47TeuCk4vkHB7p0130_assertion type Assertion NP1247677.RAejWVIaC_CyYFUIxgIRbvP80wtKpF47TeuCk4vkHB7p0130_head.
- NP1247677.RAejWVIaC_CyYFUIxgIRbvP80wtKpF47TeuCk4vkHB7p0130_assertion description "[AAVrh.10BevMab, an AAVrh.10-based vector coding for bevacizumab (Avastin), an anti-human vascular endothelial growth factor (VEGF) monoclonal antibody, was delivered to the area of the GBM xenograft.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1247677.RAejWVIaC_CyYFUIxgIRbvP80wtKpF47TeuCk4vkHB7p0130_provenance.
- NP1247677.RAejWVIaC_CyYFUIxgIRbvP80wtKpF47TeuCk4vkHB7p0130_assertion evidence source_evidence_literature NP1247677.RAejWVIaC_CyYFUIxgIRbvP80wtKpF47TeuCk4vkHB7p0130_provenance.
- NP1247677.RAejWVIaC_CyYFUIxgIRbvP80wtKpF47TeuCk4vkHB7p0130_assertion SIO_000772 25501993 NP1247677.RAejWVIaC_CyYFUIxgIRbvP80wtKpF47TeuCk4vkHB7p0130_provenance.
- NP1247677.RAejWVIaC_CyYFUIxgIRbvP80wtKpF47TeuCk4vkHB7p0130_assertion wasDerivedFrom befree-2016 NP1247677.RAejWVIaC_CyYFUIxgIRbvP80wtKpF47TeuCk4vkHB7p0130_provenance.
- NP1247677.RAejWVIaC_CyYFUIxgIRbvP80wtKpF47TeuCk4vkHB7p0130_assertion wasGeneratedBy ECO_0000203 NP1247677.RAejWVIaC_CyYFUIxgIRbvP80wtKpF47TeuCk4vkHB7p0130_provenance.